{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic54exnknlb4cqqvovq52ubxxtxkj74tr2d4la2fpn77wdxu64c4a",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgqmlgq6yi72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihzbtgvwonra54z72adwdhllrylab3cao6xkz56b56oixszzuf7qi"
    },
    "mimeType": "image/jpeg",
    "size": 411478
  },
  "path": "/news/2026-03-testosterone-prostate-cancer-surveillance.html",
  "publishedAt": "2026-03-10T20:10:05.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance. The findings, published in the Journal of Urology, suggest that baseline testosterone may serve as a useful clinical marker to better stratify risk and tailor monitoring strategies for patients choosing active surveillance.",
  "title": "Low testosterone levels may be associated with increased risk of prostate cancer progression during surveillance"
}